{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:53:32Z","timestamp":1781610812809,"version":"3.54.5"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SARS-CoV-2 is associated with systemic inflammation, vascular dysfunction, and potential ocular involvement. While structural retinal changes have been observed in some patients, the long-term impact of COVID-19 on macular architecture remains unclear, \u00a7particularly in unvaccinated populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate differences in central macular thickness (CMT) between post-COVID-19 patients and healthy individuals using optical coherence tomography (OCT), with age-stratified analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A prospective case-control study conducted at a specialized ophthalmology center in Brazil during the early vaccination phase. A total of 76 unvaccinated participants were included: 29 patients with prior COVID-19 (58 eyes) and 47 healthy controls (94 eyes). OCT was performed at least 14 days after PCR-confirmed infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall mean CMT was 246.93\u2009\u00b1\u200923.30\u00a0\u03bcm. No significant difference was found between the COVID-19 and control groups (242.54\u2009\u00b1\u200919.76\u00a0\u03bcm vs. 249.63\u2009\u00b1\u200925.06\u00a0\u03bcm;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.10). However, among participants aged\u2009\u2265\u200942 years, post-COVID-19 patients had significantly lower CMT compared to age-matched controls (241.00\u2009\u00b1\u200921.90\u00a0\u03bcm vs. 256.85\u2009\u00b1\u200928.58\u00a0\u03bcm;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). No significant difference was observed in the &lt;\u200942 years group. OCT angiography revealed no qualitative vascular abnormalities in either group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that SARS-CoV-2 infection may be associated with subtle retinal thinning in older adults, even in the absence of acute symptoms or visual complaints. These results highlight the importance of age-stratified analysis and support further investigation into the long-term ocular effects of COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-025-04177-7","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T07:59:35Z","timestamp":1754899175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantitative comparison of mean macular thickness in COVID-19 patients versus healthy individuals using optical coherence tomography"],"prefix":"10.1186","volume":"25","author":[{"given":"Nagilton Bou","family":"Ghosn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Balbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Pasquini","family":"Raiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Sayuri","family":"Vicentini Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Moreira","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Kazuo","family":"Lotto Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Silveira","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Vanalli","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Paulo","family":"Dias Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Cele Silveira","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"4177_CR1","doi-asserted-by":"publisher","first-page":"108455","DOI":"10.1016\/j.exer.2021.108455","volume":"204","author":"R Shah","year":"2021","unstructured":"Shah R, Amador C, Tormanen K, et al. Systemic diseases and the cornea. Exp Eye Res. 2021;204:108455.","journal-title":"Exp Eye Res"},{"issue":"3","key":"4177_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/09273948.2020.1738501","volume":"28","author":"I Seah","year":"2020","unstructured":"Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? Ocul Immunol Inflamm. 2020;28(3):391\u20135.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"4177_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/joim.13156","volume":"289","author":"MF Landecho","year":"2020","unstructured":"Landecho MF, Yuste JR, G\u00e1ndara E, et al. COVID-19 retinal microangiopathy. J Intern Med. 2020;289(1):116\u201320.","journal-title":"J Intern Med"},{"key":"4177_CR4","unstructured":"Abrishami M, Emamverdian Z, Shoeibi N et al. OCT angiography in recovered COVID-19 patients. Can J Ophthalmol. 2020."},{"issue":"1","key":"4177_CR5","first-page":"7483","volume":"17","author":"B Chen","year":"2019","unstructured":"Chen B, Chen H, Zheng C, et al. Performance of topcon OCT-2000. Exp Ther Med. 2019;17(1):7483\u20138.","journal-title":"Exp Ther Med"},{"issue":"10","key":"4177_CR6","first-page":"2191","volume":"258","author":"Y Lu","year":"2020","unstructured":"Lu Y, Wang JC, Cui Y, et al. Comparison of four OCT angiography devices. Graefes Arch Clin Exp Ophthalmol. 2020;258(10):2191\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4177_CR7","doi-asserted-by":"publisher","first-page":"100550","DOI":"10.1016\/j.eclinm.2020.100550","volume":"27","author":"A Invernizzi","year":"2020","unstructured":"Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in COVID-19: SERPICO-19 study. EClinicalMedicine. 2020;27:100550.","journal-title":"EClinicalMedicine"},{"key":"4177_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajo.2015.10.008","volume":"161","author":"F Coscas","year":"2016","unstructured":"Coscas F, Glacet-Bernard A, Miere A, et al. OCTA in retinal vein occlusion. Am J Ophthalmol. 2016;161:160\u201371.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"4177_CR9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/08164622.2021.1916389","volume":"104","author":"B Oren","year":"2021","unstructured":"Oren B, Aydemir GA, Aydemir E, et al. Retinal changes in COVID-19 patients. Clin Exp Optom. 2021;104(6):682\u20137.","journal-title":"Clin Exp Optom"},{"key":"4177_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40942-021-00351-3","volume":"8","author":"J Larrea","year":"2022","unstructured":"Larrea J, Villota-Deleu E, Fern\u00e1ndez-Vega B, et al. Late retinal complications in COVID-19. Int J Retina Vitreous. 2022;8:15.","journal-title":"Int J Retina Vitreous"},{"issue":"4","key":"4177_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5114\/ms.2023.134085","volume":"39","author":"M Kal","year":"2023","unstructured":"Kal M, Wroblewska M, Ciszewska J, Majchrzak A, Zaczy\u0144ska E, S\u0142oniewska D, et al. Retinal thickness in patients with elevated D-dimer and interleukin-6 levels as a result of SARS-CoV-2 infection. Med Stud. 2023;39(4):342\u201351. https:\/\/doi.org\/10.5114\/ms.2023.134085. [cited 2025 May 21];.","journal-title":"Med Stud"},{"issue":"10","key":"4177_CR12","first-page":"1356","volume":"93","author":"U Eriksson","year":"2009","unstructured":"Eriksson U, Alm A. Macular thickness decreases with age. Br J Ophthalmol. 2009;93(10):1356\u201360.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"4177_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.10.2.39","volume":"10","author":"T Etheridge","year":"2021","unstructured":"Etheridge T, Liu Z, Nalbandyan M, et al. Macular thickness in AMD and aging. Transl Vis Sci Technol. 2021;10(2):12.","journal-title":"Transl Vis Sci Technol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04177-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:15:05Z","timestamp":1781608505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-025-04177-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4177"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04177-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Grupo OPTY: HCLOE Cl\u00ednica de Oftalmologia Especializada. All participants provided written informed consent prior to participation. The study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"451"}}